Taixing Cui to Oxidative Stress
This is a "connection" page, showing publications Taixing Cui has written about Oxidative Stress.
Connection Strength
1.965
-
Targeting Nrf2 by dihydro-CDDO-trifluoroethyl amide enhances autophagic clearance and viability of ?-cells in a setting of oxidative stress. FEBS Lett. 2014 Jun 05; 588(12):2115-24.
Score: 0.334
-
Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes. 2011 Feb; 60(2):625-33.
Score: 0.266
-
An essential role of Nrf2 in American ginseng-mediated anti-oxidative actions in cardiomyocytes. J Ethnopharmacol. 2010 Jul 20; 130(2):222-30.
Score: 0.253
-
Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes. PLoS One. 2009 Dec 21; 4(12):e8391.
Score: 0.246
-
Molecules from American Ginseng Suppress Colitis through Nuclear Factor Erythroid-2-Related Factor 2. Nutrients. 2020 Jun 21; 12(6).
Score: 0.128
-
Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency. Hypertension. 2016 Jan; 67(1):107-17.
Score: 0.093
-
Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2. J Mol Cell Cardiol. 2015 Jul; 84:143-53.
Score: 0.089
-
Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid Med Cell Longev. 2014; 2014:748524.
Score: 0.083
-
Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins. J Mol Cell Cardiol. 2014 Jul; 72:305-15.
Score: 0.083
-
Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2. PLoS One. 2012; 7(9):e44899.
Score: 0.074
-
Up-regulation of p27(kip1) contributes to Nrf2-mediated protection against angiotensin II-induced cardiac hypertrophy. Cardiovasc Res. 2011 May 01; 90(2):315-24.
Score: 0.066
-
Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Arterioscler Thromb Vasc Biol. 2009 Nov; 29(11):1843-50.
Score: 0.060
-
Targeting the Nrf2 pathway against cardiovascular disease. Expert Opin Ther Targets. 2009 Jul; 13(7):785-94.
Score: 0.060
-
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3?/Fyn pathway. Redox Biol. 2018 05; 15:405-417.
Score: 0.027
-
Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein. Free Radic Biol Med. 2017 11; 112:224-239.
Score: 0.026
-
Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation. J Mol Cell Cardiol. 2013 Apr; 57:82-95.
Score: 0.019
-
Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-?B. Am J Physiol Heart Circ Physiol. 2013 Feb 15; 304(4):H567-78.
Score: 0.019
-
Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis. Arterioscler Thromb Vasc Biol. 2012 May; 32(5):1158-66.
Score: 0.018
-
Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis. Hypertension. 2004 Nov; 44(5):758-63.
Score: 0.011
-
Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan. Hypertension. 2004 Feb; 43(2):263-9.
Score: 0.010